143 related articles for article (PubMed ID: 32023386)
1. Ligelizumab for Chronic Spontaneous Urticaria. Reply.
Maurer M; Giménez-Arnau AM; Metz M
N Engl J Med; 2020 Feb; 382(6):579-580. PubMed ID: 32023386
[No Abstract] [Full Text] [Related]
2. Ligelizumab for Chronic Spontaneous Urticaria. Reply.
Center DM
N Engl J Med; 2020 Feb; 382(6):580. PubMed ID: 32023387
[No Abstract] [Full Text] [Related]
3. Ligelizumab Is Superior to Omalizumab for Chronic Spontaneous Urticaria.
Muntyanu A; Ouchene L; Ben-Shoshan M; Netchiporouk E
J Cutan Med Surg; 2020; 24(2):201-202. PubMed ID: 32208012
[No Abstract] [Full Text] [Related]
4. Ligelizumab for Chronic Spontaneous Urticaria.
Weinberger M
N Engl J Med; 2020 Feb; 382(6):579. PubMed ID: 32023385
[No Abstract] [Full Text] [Related]
5. Ligelizumab for Chronic Spontaneous Urticaria.
Cohen JM
N Engl J Med; 2020 Feb; 382(6):579. PubMed ID: 32023384
[No Abstract] [Full Text] [Related]
6. Ligelizumab for the treatment of chronic spontaneous urticaria.
Wedi B
Expert Opin Biol Ther; 2020 Aug; 20(8):853-861. PubMed ID: 32380864
[
